Richard M. Glickman

Insider Reports History

Entity
Individual
Location
C/O Aspreva Pharmaceuticals Corporation, 1203 4464 Markham Street, Victoria, British Columbia, Canada
Signature
/s/ Alex J. Nichols, as attorney-in-fact for the Reporting Person
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard M. Glickman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ESSA Pharma Inc. Director Common Shares 43.2K $212K $4.90 Apr 24, 2024 Direct
enGene Holdings Inc. Director Common Shares 24.7K $22K $0.89 May 28, 2024 Direct
enGene Holdings Inc. Director Stock Option (Right to Buy) 20K Jun 15, 2024 Direct
ESSA Pharma Inc. Director Options 0 Apr 24, 2024 Direct

Insider Reports Filed by Richard M. Glickman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ENGN enGene Holdings Inc. Jun 15, 2024 1 $0 4 Jun 18, 2024 Director
ENGN enGene Holdings Inc. May 28, 2024 2 $107 4 May 29, 2024 Director
EPIX ESSA Pharma Inc. Apr 24, 2024 2 $18.4K 4 Apr 25, 2024 Director
EPIX ESSA Pharma Inc. Mar 25, 2024 1 $0 4 Mar 28, 2024 Director
ENGN enGene Holdings Inc. Oct 31, 2023 9 $0 4 Nov 2, 2023 Director
ENGN enGene Holdings Inc. Oct 31, 2023 0 $0 3 Oct 31, 2023 Director
EPIX ESSA Pharma Inc. Jun 29, 2022 1 $0 4 Nov 1, 2022 Director